evidence table

Boswellia Joint Comfort Randomized Trial Evidence Table

Structured evidence table for Boswellia Joint Comfort Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Boswellia Joint Comfort Randomized TrialThe relationship between the immune system and metabolic diseases is complex and increasingly recognized as critical to understanding conditions like obesity, diabetes, and cardiovascular diseases.3Febriyanti RM (2024)Immunomodulatory Role of Plants and Their Constituents on the Management of Metabolic Disorders: An Evidence-Based Review.
Boswellia Joint Comfort Randomized TrialModulation of the immune system in patients with metabolic disorders can offer several potential benefits.3Febriyanti RM (2024)Immunomodulatory Role of Plants and Their Constituents on the Management of Metabolic Disorders: An Evidence-Based Review.
Boswellia Joint Comfort Randomized TrialSubsequently, a practical "What-How-When" framework is introduced to guide community pharmacists in risk screening, DMOAD selection, chronotherapeutic dosing, safety monitoring, and lifestyle integration, as exemplified by the CHONDROMOVING infographic brochure designed for diverse health literacy levels.4Del Río E (2025)Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.
Boswellia Joint Comfort Randomized TrialBuilding on these strategies, the P4-4P Chondroprotection Framework is proposed, integrating predictive risk profiling (physicians), preventive pharmacokinetic and chronotherapy optimization (pharmacists), personalized biomechanical interventions (physiotherapists), and participatory self-management (patients) into a unified, feedback-driven OA care model.4Del Río E (2025)Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.
Boswellia Joint Comfort Randomized TrialOsteoarthritis (OA) remains a major contributor to pain and disability; however, the current management is largely reactive, focusing on symptoms rather than preventing irreversible cartilage loss.4Del Río E (2025)Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.
topicBoswellia Joint Comfort Randomized Trial
claimThe relationship between the immune system and metabolic diseases is complex and increasingly recognized as critical to understanding conditions like obesity, diabetes, and cardiovascular diseases.
evidence level3
citationFebriyanti RM (2024)
sourceImmunomodulatory Role of Plants and Their Constituents on the Management of Metabolic Disorders: An Evidence-Based Review.
topicBoswellia Joint Comfort Randomized Trial
claimModulation of the immune system in patients with metabolic disorders can offer several potential benefits.
evidence level3
citationFebriyanti RM (2024)
sourceImmunomodulatory Role of Plants and Their Constituents on the Management of Metabolic Disorders: An Evidence-Based Review.
topicBoswellia Joint Comfort Randomized Trial
claimSubsequently, a practical "What-How-When" framework is introduced to guide community pharmacists in risk screening, DMOAD selection, chronotherapeutic dosing, safety monitoring, and lifestyle integration, as exemplified by the CHONDROMOVING infographic brochure designed for diverse health literacy levels.
evidence level4
citationDel Río E (2025)
sourcePharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.
topicBoswellia Joint Comfort Randomized Trial
claimBuilding on these strategies, the P4-4P Chondroprotection Framework is proposed, integrating predictive risk profiling (physicians), preventive pharmacokinetic and chronotherapy optimization (pharmacists), personalized biomechanical interventions (physiotherapists), and participatory self-management (patients) into a unified, feedback-driven OA care model.
evidence level4
citationDel Río E (2025)
sourcePharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.
topicBoswellia Joint Comfort Randomized Trial
claimOsteoarthritis (OA) remains a major contributor to pain and disability; however, the current management is largely reactive, focusing on symptoms rather than preventing irreversible cartilage loss.
evidence level4
citationDel Río E (2025)
sourcePharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.

Learn next

Related evidence and supplement guides

SupplementCollagen PeptidesHydrolysed collagen that stimulates fibroblasts — evidence for joints, skin elasticity, and tend...GuideBoswellia Joint Comfort Randomized Trial: What the Evidence SaysBoswellia Joint Comfort Randomized Trial has 2 source documents in the current Migaku evidence d...GuideRosehip Joint Comfort Randomized Trial: What the Evidence SaysRosehip Joint Comfort Randomized Trial has 1 source documents in the current Migaku evidence dat...GuideGlucosamine Joint Comfort Randomized Trial: What the Evidence SaysGlucosamine Joint Comfort Randomized Trial has 2 source documents in the current Migaku evidence...GuideCollagen Joint Pain Randomized Trial: What the Evidence SaysCollagen Joint Pain Randomized Trial has 3 source documents in the current Migaku evidence datab...AnswerDoes Boswellia Joint Comfort Randomized Trial work?Boswellia Joint Comfort Randomized Trial has evidence relevant to strength of evidence and what...AnswerIs Boswellia Joint Comfort Randomized Trial safe?Boswellia Joint Comfort Randomized Trial has evidence relevant to safety, limits, and clinician-...AnswerWhat does the evidence say about Boswellia Joint Comfort Randomized Trial?Boswellia Joint Comfort Randomized Trial has evidence relevant to benefits, uncertainty, and pra...

Source documents

  1. Immunomodulatory Role of Plants and Their Constituents on the Management of Metabolic Disorders: An Evidence-Based Review.
  2. Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.